$IAUX

i-80 Gold Reports Second Quarter 2026 Results; On Track to Achieve Full-Year Guidance as Granite Creek Ramps Up and Development Plan Advances

i-80 Gold Corp. (NYSE:IAUX, TSX:IAU) reported Q2 2026 results for the three and six months ended June 30, 2026. Revenues fell to $24.3M from $27.8M, while gold production rose to 11,098 oz from 4,178 oz. Net loss widened to $52.5M. The company said it remains on track for 2026 guidance and targets first gold at Archimedes in Q4 2026.

Original reporting
Published Aug 10, 2026, 10:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 10, 2026, 11:25 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
i-80 Gold Reports Second Quarter 2026 Results; On Track to Achieve Full-Year Guidance as Granite Creek Ramps Up and Development Plan Advances — source image
Decision brief

The 30-second read

$IAUXNeutralMed
01

Why it matters

This quarter’s disclosure updates traders on production, revenue drivers, cash burn, and the schedule for major catalysts in Q4 2026 and beyond, while reiterating full-year guidance subject to capex and exploration expense expectations.

02

Market read

Traders get a fresh checkpoint on execution progress and cash burn, plus explicit milestone timing into Q4 2026, which can drive valuation and risk premium for the stock.

03

What to watch

Key near-term risk is third-party processing availability at Granite Creek and the pace of capital commitment and procurement (only ~40% committed and ~50% packages awarded by mid-July), which could affect milestone timing.

Relevance 8/10Novelty 7/10Timing: after-hours today, with Q4 2026 milestone timing reiterated

Background

i-80 Gold is advancing multiple Nevada assets concurrently, including Granite Creek (ramping underground), Archimedes (second underground mine), and Lone Tree (plant refurbishment and construction).

Company-level read

Ticker impact

$IAUXNeutralMedium confidence
Context

i-80 Gold reports Q2 2026 results and says Granite Creek is ramping, Archimedes is on schedule, and Lone Tree demolition started mid-June.

Expected impact

Near-term bias depends on whether investors focus on the revenue decline from Granite Creek processing delays versus the production rebound and reiterated guidance.

Evidence & confidence

The release contains concrete operating updates (production up, drilling meters completed) and specific upcoming catalysts (first gold mined Q4 2026, commence construction Q4 2026), but it also discloses a larger net loss and revenue decline tied to third-party processing delays.

Market effects

Reinforces the execution risk and working-capital sensitivity typical of mid-tier gold developers, with third-party processing availability a key swing factor.

Highlights ongoing Nevada project development cadence, which can influence local permitting and contractor activity expectations.

Limited direct global read-through beyond sentiment toward gold project execution and near-term production ramp credibility.

Counterpoint

The revenue decline and much larger net loss suggest the ramp is still being offset by processing delays and rising pre-development costs, so the “on track” message may not translate into near-term earnings power.

Key entities

  • i-80 Gold Corp.

    Reports Q2 2026 financials and development milestones, including Archimedes and Lone Tree schedule updates and guidance outlook.

  • Granite Creek

    Underground development ramping ahead of plan; production increased but revenue fell due to third-party processing facility delays.

  • Archimedes

    Underground development advanced on schedule; ventilation raise commenced, targeting first gold mined in Q4 2026.

  • Lone Tree Plant

    Refurbishment demolition started mid-June; management targets major construction commencement in Q4 2026.

Related articles

$IAUXMed

i-80 Gold Corp. & The Nevada Processing Moat: Institutional Buy-Side Analysis of Second Quarter 2026 Execution & Capital Structure - Article

i-80 Gold Corp. produced 11,098 ounces of gold in Q2 2026, with 8,634 ounces from Granite Creek. The company has US$464.6 million in cash and is advancing a US$430 million Lone Tree autoclave refurbishment, targeting first gold by year-end 2027. Mineral Point's PFS is now expected mid-2027. The company faces contractor staffing and drill-rig shortages, impacting study timelines.

$IAUXMed

i-80 Gold (IAUX) Q2 2026 Earnings Call Transcript

i-80 Gold (IAUX) held its Q2 2026 earnings call, discussing progress at Granite Creek Underground and Archimedes. Granite Creek Q2 production rose to about 8.6k oz gold, with YTD about 17.5k oz, on track for 2026 guidance of 30k to 40k oz. Updated Granite Creek resource supports a feasibility study planned for Q3 2026; Archimedes first gold is targeted for Q4 2026.

$IAUXMed

i-80 Gold Corp. (IAUX): Results of Operations and Financial Condition

i-80 Gold Corp. (IAUX) filed an SEC Form 8-K — Results of Operations and Financial Condition. i-80 Gold Reports Second Quarter 2026 Results; On Track to Achieve Full-Year Guidance as Granite Creek Ramps Up and Development Plan Advances TORONTO, ON, August 10 , 2 026 – i-80 GOLD CORP. (NYSE:IAUX) (TSX:IAU) (“i-80 Gold” or the “Company”) reports its financial and operating

Med

Green Thumb Industries: Is This Profitable Cannabis Stock Still Undervalued?

Green Thumb Industries (GTBIF) reported Q2 revenue of $306.7M, EBITDA of $84.3M, and net income of $4.9M. The company grew revenue by 4.6% YoY and maintains a strong balance sheet with $283.6M in cash and $283M in debt. It repurchased 7.9M shares in Q2. Despite challenges, its financial flexibility and potential federal reform make it a notable player in the cannabis industry.

$MDTMedAI 8/10

Can Medtronic’s (MDT) Core Units Keep Up With Management’s New Bets?

Medtronic (MDT) reported strong Q1 results, raising its fiscal 2027 revenue growth outlook to 7.25-7.75%. The company is investing in high-growth areas like robotic surgery and partnerships, such as a $700M deal for Cornerstone's Sentire Surgical System. However, it faces stiff competition from peers like Johnson & Johnson and Intuitive Surgical. Institutional investors, including BlackRock, are increasing their stakes in MDT.